Price
Target price
€38.86
€38.86
1.280%
0.5
1.280%
€56.86
22:26 / Tradegate
WKN: A2ACMZ / Symbol: IONS / Name: Ionis Pharmaceuticals / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ionis Pharmaceuticals Inc. Stock
There is an upward development for Ionis Pharmaceuticals Inc. compared to yesterday, with an increase of €0.50 (1.280%).
Currently there is a rather positive sentiment for Ionis Pharmaceuticals Inc. with 17 Buy predictions and 5 Sell predictions.
As a result the target price of 56 € shows a positive potential of 44.11% compared to the current price of 38.86 € for Ionis Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Ionis Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 1.280% | 1.721% | -3.751% | 19.230% | -14.605% | 10.450% | -41.441% |
| Novocure Ltd | 3.070% | 0.751% | -6.366% | -79.489% | -20.140% | -93.120% | - |
| Sage Therapeutics Inc. | -0.350% | 7.594% | -26.705% | -70.648% | -36.600% | -79.905% | - |
| Iovance Biotherapeutics Inc. | -1.440% | -2.226% | -20.178% | 108.608% | 37.807% | -58.359% | - |
Comments
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $58.00 price target on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Show more
Ratings data for IONS provided by MarketBeat
